Welcome

FazaClo® (clozapine, USP) is a unique orally disintegrating tablet formulation of clozapine. FazaClo is an antipsychotic drug indicated for the management of severely ill schizophrenic patients who fail to respond to standard treatments. FazaClo also is indicated for reduction in the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorders. FazaClo is supported by a sales infrastructure consisting of 50 specialty sales representatives as well as a field–based team of Clinical Compliance Liaisons. In addition, FazaClo has a patient registry team, who provide 24/7 assistance to healthcare professionals and patients.

PLEASE SEE THE FOLLOWING IMPORTANT SAFETY INFORMATION FOR FAZACLO